Double renal cell carcinoma with histological type of clear cell carcinoma and papillary carcinoma in the same kidney concurrently treated with robot-assisted partial nephrectomy.

clear cell renal carcinoma ipsilateral papillary type1 renal cell carcinoma robot‐assisted partial nephrectomy

Journal

IJU case reports
ISSN: 2577-171X
Titre abrégé: IJU Case Rep
Pays: Australia
ID NLM: 101764958

Informations de publication

Date de publication:
Jan 2022
Historique:
received: 24 07 2021
revised: 08 09 2021
accepted: 13 10 2021
entrez: 10 1 2022
pubmed: 11 1 2022
medline: 11 1 2022
Statut: epublish

Résumé

The presence of two different histologic types of renal cell carcinoma in the same kidney is rare in clinical practice. This report describes a patient with ipsilateral renal cell carcinomas, consisting of a clear cell renal cell carcinoma and a papillary type 1 renal cell carcinoma, who was successfully treated by robot-assisted partial nephrectomy. A 70-year man was referred to our hospital for the treatment of two right mid-pole renal tumors, measuring 51 mm and 31 mm in diameter. The two tumors, which differed in contrast enhancement on computed tomography, were removed simultaneously by robot-assisted partial nephrectomy. Histopathological and immunohistochemical findings confirmed that one tumor was a clear cell renal cell carcinoma, pT1a, and the other was a papillary type1 renal cell carcinoma, pT1b. This report describes a rare patient presenting with two ipsilateral renal cell carcinomas differing in histology. Robot-assisted partial nephrectomy was the safe and effective nephron-sparing surgery, even in patients with complex double renal tumors.

Identifiants

pubmed: 35005477
doi: 10.1002/iju5.12395
pii: IJU512395
pmc: PMC8720717
doi:

Types de publication

Case Reports

Langues

eng

Pagination

62-65

Informations de copyright

© 2021 The Authors. IJU Case Reports published by John Wiley & Sons Australia, Ltd on behalf of Japanese Urological Association.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

N Engl J Med. 2005 Dec 8;353(23):2477-90
pubmed: 16339096
Eur Urol. 2019 May;75(5):799-810
pubmed: 30803729
Urol Oncol. 2018 Jan;36(1):11.e7-11.e12
pubmed: 28993058
Mod Pathol. 1997 Jun;10(6):537-44
pubmed: 9195569
J Cancer Res Clin Oncol. 2017 Sep;143(9):1845-1851
pubmed: 28451753
Acta Radiol. 2009 Dec;50(10):1187-92
pubmed: 19922319
Clin Genitourin Cancer. 2016 Apr;14(2):e171-5
pubmed: 26613833

Auteurs

Teruki Shimizu (T)

Department of Urology Kyoto Prefectural University of Medicine Kyoto Japan.

Fumiya Hongo (F)

Department of Urology Kyoto Prefectural University of Medicine Kyoto Japan.

Hikaru Takahashi (H)

Department of Urology Kyoto Prefectural University of Medicine Kyoto Japan.

Atsuko Fujihara (A)

Department of Urology Kyoto Prefectural University of Medicine Kyoto Japan.

Osamu Ukimura (O)

Department of Urology Kyoto Prefectural University of Medicine Kyoto Japan.

Classifications MeSH